| Loop diuretic use | p value | |||
---|---|---|---|---|---|
Yes (n = 2364) | No (n = 2364) | ||||
n | % | n | % | ||
Age (years) | 0.645 | ||||
 < 60 | 398 | 16.8 | 375 | 15.9 |  |
 60–79 | 1306 | 55.3 | 1314 | 55.6 | |
 ≥ 80 | 660 | 27.9 | 675 | 28.5 | |
Gender | 0.792 | ||||
 Male | 1344 | 56.9 | 1335 | 56.5 |  |
 Female | 1020 | 43.1 | 1029 | 43.5 | |
Income level (NTD) | 0.215 | ||||
 Financially dependent | 822 | 34.8 | 821 | 34.7 |  |
 1–19,999 | 1283 | 54.3 | 1323 | 56.0 | |
 20,000–39,999 | 188 | 7.9 | 167 | 7.1 | |
  ≥ 40,000 | 71 | 3.0 | 53 | 2.2 | |
Urbanization level | 0.943 | ||||
 1 (Most urbanized) | 542 | 22.9 | 541 | 22.9 |  |
 2 | 604 | 25.6 | 612 | 25.9 | |
 3 | 403 | 17.1 | 402 | 17.0 | |
 4 | 469 | 19.8 | 449 | 19.0 | |
 5 (Least urbanized) | 346 | 14.6 | 360 | 15.2 | |
Stroke type | 0.524 | ||||
 Ischemic | 1431 | 60.5 | 1467 | 62.0 |  |
 Hemorrhagic | 373 | 15.8 | 380 | 16.1 | |
 TIA | 321 | 13.6 | 298 | 12.6 | |
 Others | 239 | 10.1 | 219 | 9.3 | |
Charlson comorbidity index | 0.415 | ||||
 1–2 | 1073 | 45.4 | 1110 | 47.0 |  |
 3–4 | 774 | 32.7 | 733 | 31.0 | |
  ≥ 5 | 517 | 21.9 | 521 | 22.0 | |
Hypertension | 1840 | 77.8 | 1854 | 78.4 | 0.622 |
Diabetes mellitus | 970 | 41.0 | 976 | 41.3 | 0.859 |
COPD | 646 | 27.3 | 657 | 27.8 | 0.720 |
Congestive heart failure | 459 | 19.4 | 427 | 18.1 | 0.233 |
Chronic liver disease | 299 | 12.7 | 288 | 12.2 | 0.628 |
Chronic kidney disease | 379 | 16.0 | 355 | 15.0 | 0.335 |
Osteoporosis | 133 | 5.6 | 133 | 5.6 | 1.000 |
Malignancy | 190 | 8.0 | 170 | 7.2 | 0.273 |
Dementia | 169 | 7.1 | 154 | 6.5 | 0.387 |
Depression | 139 | 5.9 | 128 | 5.4 | 0.488 |
Epilepsy | 46 | 1.9 | 39 | 1.6 | 0.444 |
Parkinsonism | 121 | 5.1 | 122 | 5.2 | 0.947 |